41:
29:
435:. The company began manufacturing and marketing prescription drugs during the 1970s. In 1988, it launched Mohrus, and in 1995, Mohrus-Tape, both prescription external anti-inflammatory drugs. Salonpas Pain Relief Patch and Salonpas Arthritis Pain were approved for over the counter sales in the United States in 2008. In 2009, Hisamitsu acquired Noven Pharmaceuticals, a specialty prescription drug transdermal pharmaceutical company based in Florida.
755:
286:
262:
783:
769:
443:
Hisamitsu operates two primary bases in Japan, in Saga
Prefecture and in Tokyo. It has two subsidiaries in the United States: Hisamitsu America, Inc. in Florham Park, NJ, and Noven Pharmaceuticals in Miami, FL. It has a clinical research department in New Jersey and a research laboratory in Carlsbad,
472:
drug. According to the company, Mohrus and Mohrus-Tape have the largest market share in prescription external anti-inflammatory drugs in Japan with 54% in 2nd generation NSAID patches. The firm's over-the-counter
Salonpas products include a range of external pain relieving patches and aerosols for
377:
brands are exported to over fifty countries. Hisamitsu also manufactures the Mohrus and Mohrus-Tape lines of external pain relief prescription products for the
Japanese drug market. The company also manufactures internal medicines, eyedrops for general application, and the Lifecella Face Mask, a
459:
Hisamitsu
Pharmaceutical offers a variety of prescription and over-the-counter products, including transdermal patches and skin care products. Its product lines include the Salonpas pain relief patches; Mohrus Tape, a transdermal patch containing
405:, a poultice consisting of rubbing ointment pasted onto Japanese paper. The product line developed from this traditional remedy was introduced in 1934 and first exported to overseas markets in 1937.
578:
424:(Hisamitsu Pharmaceutical Singapore Pte. Ltd.) and in the United States (Hisamitsu America, Inc.) in 1987. Hisamitsu Vietnam Pharmaceutical Co., Ltd. was established in
849:
819:
844:
854:
839:
444:
CA. Hisamitsu also has overseas facilities in
Britain, Australia, Brazil, the Philippines, Hong Kong, Singapore, Vietnam, Indonesia, Taiwan and Malaysia.
627:
582:
366:. Hisamitsu has specialised in transdermal drug delivery system technology (TDDS) since the introduction of its original line of patches in 1903.
864:
834:
374:
111:
379:
829:
824:
490:
431:
In 1965 the company changed its name to
Hisamitsu Pharmaceutical Co., Ltd., and in 1972 it was listed on the first section of the
869:
796:
650:"Press Release relating to FDA Approval for SALONPAS® PAIN RELEAF PATCH (code: FS-67, topical analgesic product) under NDA"
541:
390:
Hisamitsu
Pharmaceutical was founded in 1847 under the name Komatsuya. It was established in Tosu, which is now in
127:
516:
428:
in 1994. In 1998 Hisamitsu U.K. opened in London and a research laboratory was established in
California.
635:
208:
378:
skincare product. Hisamitsu has developed the only over-the-counter transdermal patches approved by the
355:
119:
604:
859:
40:
137:
249:
Anti fungal, anti-inflammatory, dermatologic, central nerve system, respiratory system medicines
520:
123:
702:
359:
115:
432:
401:
The prototype of
Hisamitsu's Salonpas patch was created in 1903 through the application of
107:
8:
678:
546:
28:
494:
363:
674:
788:
93:
774:
649:
391:
347:
579:"Transdermal Drug Delivery System, transdermal patches, transdermal dosage form"
727:
631:
178:
90:
813:
398:. This region is well known in Japan for its tradition of herbal medicines.
101:
760:
555:
265:
75:
551:
269:
473:
pains such as arthritis, backache, muscle strains, sprains and bruises.
362:(OTC) products, especially external pain relieving products such as the
461:
278:
232:
174:
165:
49:
358:
pharmaceutical corporation that develops and markets prescription and
469:
465:
421:
413:
451:
products for the United States and Canada. It was founded in 1987.
448:
370:
236:
226:
464:
for the treatment of back pain; Vesicum, a formulation containing
425:
628:"Hisamitsu Wins U.S. FDA Approval for Pain Relieving Skin Patch"
417:
416:(PT Hisamitsu Pharma Indonesia). More subsidiaries followed in
409:
395:
351:
240:
655:(Press release). Hisamitsu Pharmaceutical. February 22, 2008
576:
447:
Hisamitsu
America is the sole importer and distributor of
308:
212:
804:
420:(Hisamitsu Farmaceutica do Brasil Ltda.) in 1986, in
750:
412:
in 1960. In 1975 a joint company was established in
55:
Kalbe/Hisamitsu Pharmaceuticals (Adventure Bay) Inc.
811:
468:piconol; and Estrana, a transdermal therapeutic
339:
289:JPY 21.35 billion (US$ 209.5 million) (FY 2013)
850:Companies listed on the Fukuoka Stock Exchange
820:Multinational companies headquartered in Japan
333:
65:
845:Companies listed on the Nagoya Stock Exchange
855:Pharmaceutical companies established in 1847
840:Companies listed on the Tokyo Stock Exchange
697:
695:
299:2,949 (consolidated, as of 28 February 2014)
675:"Hisamitsu Buys Drug Maker Noven - WSJ.com"
493:. Hisamitsu Pharmaceutical. Archived from
39:
27:
728:"Hisamitsu America Inc - Company Profile"
692:
625:
865:Japanese companies established in 1847
835:Manufacturing companies based in Tokyo
812:
672:
626:Matsuyama, Kanoko (18 October 2009).
268:150.63 billion (US$ 1.47 billion) (
16:Japanese pharmaceutical corporation
13:
830:Companies based in Saga Prefecture
797:Hisamitsu Pharmaceutical Co., Inc.
408:A subsidiary branch was opened in
341:Hisamitsu Seiyaku kabushiki gaisha
329:Hisamitsu Pharmaceutical Co., Inc.
82:Hisamitsu Seiyaku kabushiki gaisha
22:Hisamitsu Pharmaceutical Co., Inc.
14:
881:
825:Pharmaceutical companies of Japan
746:
577:Geeta Aggarwal Dr. Sanju Dhawan.
781:
767:
753:
581:. Pharmainfo.net. Archived from
380:U.S Food and Drug Administration
285:
284:
261:
260:
720:
369:Hisamitsu's products under the
319:Footnotes / references
870:1960s initial public offerings
673:Grace, Kerry (July 15, 2009).
666:
642:
619:
597:
570:
534:
509:
483:
229:and other pain relief products
1:
476:
438:
149:; 177 years ago
7:
805:Noven Pharmaceuticals, Inc.
454:
340:
10:
886:
708:. Hisamitsu Pharmaceutical
607:. Hisamitsu Pharmaceutical
385:
334:
317:
303:
293:
276:
256:
219:
199:
189:
161:
143:
133:
99:
86:
73:
66:
59:
47:
38:
26:
521:Bloomberg Businessweek
491:"Financial Highlights"
360:over-the-counter drug
703:"ANNUAL REPORT 2009"
558:on December 26, 2017
433:Tokyo Stock Exchange
679:Wall Street Journal
605:"Hisamitsu History"
547:Nikkei Asian Review
394:, on the island of
346:, headquartered in
295:Number of employees
23:
517:"Company Snapshot"
170:Kyushu head office
21:
542:"Company Profile"
497:on April 30, 2017
364:transdermal patch
325:
324:
205:Hirotaka Nakatomi
183:Tokyo head office
181:100-6330, Japan (
168:841-0017, Japan (
877:
801:
791:
789:Companies portal
786:
785:
784:
777:
772:
771:
770:
763:
758:
757:
756:
740:
739:
737:
735:
724:
718:
717:
715:
713:
707:
699:
690:
689:
687:
685:
670:
664:
663:
661:
660:
654:
646:
640:
639:
623:
617:
616:
614:
612:
601:
595:
594:
592:
590:
585:on June 26, 2010
574:
568:
567:
565:
563:
538:
532:
531:
529:
527:
513:
507:
506:
504:
502:
487:
354:, is a Japanese
345:
343:
337:
336:
313:
310:
288:
287:
264:
263:
157:
155:
150:
69:
68:
43:
31:
24:
20:
885:
884:
880:
879:
878:
876:
875:
874:
860:Japanese brands
810:
809:
799:
787:
782:
780:
775:Medicine portal
773:
768:
766:
759:
754:
752:
749:
744:
743:
733:
731:
726:
725:
721:
711:
709:
705:
701:
700:
693:
683:
681:
671:
667:
658:
656:
652:
648:
647:
643:
624:
620:
610:
608:
603:
602:
598:
588:
586:
575:
571:
561:
559:
540:
539:
535:
525:
523:
515:
514:
510:
500:
498:
489:
488:
484:
479:
457:
441:
392:Saga Prefecture
388:
331:
321:
307:
296:
281:
252:
206:
202:
192:
173:
153:
151:
148:
138:Pharmaceuticals
122:
114:
104:
79:
62:
52:
34:
33:Logo since 2003
17:
12:
11:
5:
883:
873:
872:
867:
862:
857:
852:
847:
842:
837:
832:
827:
822:
808:
807:
802:
793:
792:
778:
764:
748:
747:External links
745:
742:
741:
719:
691:
665:
641:
638:on 2015-05-25.
634:Archived from
632:Bloomberg L.P.
618:
596:
569:
554:Archived from
533:
508:
481:
480:
478:
475:
456:
453:
440:
437:
403:asahi mankinko
387:
384:
323:
322:
315:
314:
305:
301:
300:
297:
294:
291:
290:
282:
277:
274:
273:
258:
254:
253:
251:
250:
247:
244:
230:
223:
221:
217:
216:
203:
200:
197:
196:
193:
190:
187:
186:
179:Chiyoda, Tokyo
163:
159:
158:
145:
141:
140:
135:
131:
130:
105:
100:
97:
96:
88:
84:
83:
80:
74:
71:
70:
63:
60:
57:
56:
53:
48:
45:
44:
36:
35:
32:
15:
9:
6:
4:
3:
2:
882:
871:
868:
866:
863:
861:
858:
856:
853:
851:
848:
846:
843:
841:
838:
836:
833:
831:
828:
826:
823:
821:
818:
817:
815:
806:
803:
798:
795:
794:
790:
779:
776:
765:
762:
751:
729:
723:
704:
698:
696:
680:
676:
669:
651:
645:
637:
633:
629:
622:
606:
600:
584:
580:
573:
557:
553:
549:
548:
543:
537:
522:
518:
512:
496:
492:
486:
482:
474:
471:
467:
463:
452:
450:
445:
436:
434:
429:
427:
423:
419:
415:
411:
406:
404:
399:
397:
393:
383:
381:
376:
375:Bye-Bye Fever
372:
367:
365:
361:
357:
356:multinational
353:
349:
342:
330:
320:
316:
312:
306:
302:
298:
292:
283:
280:
275:
271:
267:
259:
255:
248:
245:
242:
238:
234:
231:
228:
225:
224:
222:
218:
214:
210:
204:
198:
194:
188:
184:
180:
176:
171:
167:
164:
160:
146:
142:
139:
136:
132:
129:
125:
121:
117:
113:
109:
106:
103:
98:
95:
92:
89:
85:
81:
77:
72:
64:
58:
54:
51:
46:
42:
37:
30:
25:
19:
800:(in English)
761:Japan portal
732:. Retrieved
722:
712:November 27,
710:. Retrieved
682:. Retrieved
668:
657:. Retrieved
644:
636:the original
621:
609:. Retrieved
599:
587:. Retrieved
583:the original
572:
560:. Retrieved
556:the original
545:
536:
524:. Retrieved
511:
499:. Retrieved
495:the original
485:
458:
446:
442:
430:
407:
402:
400:
389:
368:
328:
326:
318:
243:(Japan-only)
182:
169:
162:Headquarters
87:Company type
18:
730:. Manta.com
552:Nikkei Inc.
191:Area served
61:Native name
814:Categories
659:2021-03-11
477:References
462:ketoprofen
311:.hisamitsu
279:Net income
233:Robitussin
201:Key people
175:Marunouchi
166:Tosu, Saga
50:Trade name
562:August 7,
470:estradiol
466:ibuprofen
439:Locations
422:Singapore
414:Indonesia
246:Eye drops
209:President
195:Worldwide
102:Traded as
76:Romanized
526:April 6,
501:April 6,
455:Products
449:Salonpas
371:Salonpas
335:久光製薬株式会社
237:Caltrate
227:Salonpas
220:Products
134:Industry
67:久光製薬株式会社
734:May 12,
684:May 12,
611:May 12,
589:May 12,
426:Vietnam
386:History
382:(FDA).
304:Website
257:Revenue
152: (
144:Founded
418:Brazil
410:Taiwan
396:Kyushu
309:global
91:Public
706:(PDF)
653:(PDF)
352:Tokyo
272:2013)
241:Advil
736:2010
714:2013
686:2010
613:2010
591:2010
564:2017
528:2015
503:2015
373:and
350:and
348:Saga
327:The
211:and
154:1847
147:1847
128:4530
120:4530
112:4530
78:name
266:JPY
213:CEO
124:FSE
116:NAG
108:TYO
816::
694:^
677:.
630:.
550:.
544:.
519:.
338:,
270:FY
239:,
235:,
177:,
126::
118::
110::
94:KK
738:.
716:.
688:.
662:.
615:.
593:.
566:.
530:.
505:.
344:)
332:(
215:)
207:(
185:)
172:)
156:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
